Atlas Trials

Classic Hodgkin Lymphoma

25 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Classic Hodgkin Lymphoma

RecordFirmDate
Safety and Efficacy of IMM01 Plus Tislelizumab in Patients With Advanced Solid Tumors and Lymphomas (NCT05833984)ImmuneOnco Biopharmaceuticals (Shanghai) Inc.2022-05-17
A Study of SAR444245 With or Without Other Anticancer Therapies for the Treatment of Adults and Adolescents With Relapsed or Refractory B Cell Lymphoma (Master Protocol) [Pegathor Lymphoma 205] (NCT05179603)Sanofi2021-12-07
Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma (NCT03712202)City of Hope Medical Center2018-11-28
Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma (NCT03233347)Academic and Community Cancer Research United2017-10-13
Nivolumab & Brentuximab Vedotin Consolidation After Autologous SCT in Patients With High-Risk Classical Hodgkin Lymphoma (NCT03057795)City of Hope Medical Center2017-04-03
Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma (NCT02758717)Academic and Community Cancer Research United2016-05-13
Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma (NCT02166463)National Cancer Institute (NCI)2015-03-19
Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma (NCT01771107)National Cancer Institute (NCI)2013-03-08
Brentuximab Vedotin with Adriamycin, Vinblastine and Dacarbazine for Patients Aged 18-59 Years with Untreated Advanced-stage Classical Hodgkin Lymphoma: a Real-life Experience (NCT06857500)Federico II University2013-01-01
Liposomal Doxorubicin-containing Front-line Treatment in Elderly Patients With HL (HL-MVD) (NCT06235047)Federico II University2013-01-01
Combination Chemotherapy With or Without Rituximab in Treating Participants With Stage III-IV Classic Hodgkin Lymphoma (NCT00654732)M.D. Anderson Cancer Center2008-03-19

Track Classic Hodgkin Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.